Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Cancer drug approvals and setbacks in 2025

Nature Cancer volume 6, pages 1902–1904 (2025)Cite this article

Bispecific antibodies and ADCs battle for the limelight, CAR-T therapy sees late surge and China’s growth continues.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Senior, M. Nature https://doi.org/10.1038/d43747-025-00006-4 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Liu, A. Fierce Pharma https://go.nature.com/4rhy8sf (19 October 2025).

  3. Mullard, A. Nat. Rev. Drug Discovery 24, 573–576 (2025).

    Article  PubMed  CAS  Google Scholar 

  4. Chen, Z. et al. Lancet 406, 2078–2088 (2025).

    Article  PubMed  CAS  Google Scholar 

  5. Armstrong, M. ApexOnco https://bit.ly/4oFPddE (20 May 2025).

  6. van Herpen, C. M. L. et al. J. Clin. Oncol. 43, 6024–6024 (2025).

    Article  Google Scholar 

  7. Wang, W. et al. Cancer Metastasis Rev. 44, 23 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Janjigian, Y. Y. et al. Nat. Med. https://doi.org/10.1038/s41591-025-04022-w (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Willyard, C. Nature 641, 1090–1092 (2025).

    Article  PubMed  CAS  Google Scholar 

  10. Mullard, A. Nat. Rev. Drug Discovery 24, 653 (2025).

    Article  PubMed  CAS  Google Scholar 

  11. Senior, M. Nat. Cancer https://doi.org/10.1038/s43018-025-01044-8 (2025).

    Article  PubMed  Google Scholar 

  12. Mullard, A. Nat. Rev. Drug Discovery 24, 730 (2025).

    Article  PubMed  CAS  Google Scholar 

  13. Mullard, A. Nat. Rev. Drug Discovery 24, 408 (2025).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. London, UK

    Melanie Senior

Authors
  1. Melanie Senior
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Melanie Senior.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Senior, M. Cancer drug approvals and setbacks in 2025. Nat Cancer 6, 1902–1904 (2025). https://doi.org/10.1038/s43018-025-01080-4

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s43018-025-01080-4

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing